ETF Managers Group’s Altimmune ALT Stock Holding History

ETF Managers Group’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$69K	Sell	16,361 -121,835	-88%	-$1.45M	﹤0.01%	655
2022 Q4	$2.27M	Buy	138,196 +123,729	+855%	+$1.39M	0.11%	103
2022 Q3	$185K	Buy	14,467 +812	+6%	+$12K	0.01%	604
2022 Q2	$161K	Buy	13,655 +1,601	+13%	+$9.87K	﹤0.01%	663
2022 Q1	$73K	Sell	12,054 -13	-0.1%	-$96	﹤0.01%	645
2021 Q4	$108K	Sell	12,067 -39,945	-77%	-$424K	﹤0.01%	632
2021 Q3	$664K	Buy	+52,012	New	+$633K	0.01%	423

Other funds holding ALT

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

ETF Managers Group's ALT Position: Q1 2023 in Review

ETF Managers Group reduced its Altimmune (ALT) stake by 88% in Q1 2023, selling an estimated $1.45M and leaving 16,361 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #655.

ETF Managers Group first reported a position in ALT in Q3 2021 and has held it in 7 quarters since. The position peaked at $2.27M in Q4 2022. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.

ETF Managers Group held 16,361 shares of Altimmune worth $69K as of Q1 2023.
ETF Managers Group sold 121,835 Altimmune shares in Q1 2023, an estimated $1.45M.
Altimmune made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #655 holding.
ETF Managers Group first reported a position in Altimmune in Q3 2021 and has held it in 7 quarters since.
ETF Managers Group's Altimmune position peaked at $2.27M in Q4 2022.
132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.